Safety and Tolerability of Human Placenta-Derived Cells (PDA001) in Treatment-Resistant Crohn’s Disease: A Phase 1 Study

BACKGROUND: The clinical utility of cellular therapies is being investigated in a broad range of therapeutic areas. This phase 1 study represents the first exploration of PDA001, a preparation of cells cultured from human placental tissue, in subjects with Crohn’s disease. METHODS: Twelve subjects w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Inflamm Bowel Dis
Main Authors: Mayer, Lloyd, Pandak, William M., Melmed, Gil Y., Hanauer, Stephen B., Johnson, Kristine, Payne, Denise, Faleck, Herbert, Hariri, Robert J., Fischkoff, Steven A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4272923/
https://ncbi.nlm.nih.gov/pubmed/23429460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0b013e31827f27df
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados